Annals of Diagnostic Pathology
Volume 13, Issue 5 , Pages 297-302 , October 2009

Asbestosis: demonstration of distinctive interstitial fibroelastosis: A pilot study

  • Mark R. Wick, MD

      Affiliations

    • Divisions of Surgical Pathology, University of Virginia Medical Center, Charlottesville, VA 22908-0214, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 434 242 2410; fax: +1 434 924 9617.
    • ,
  • Todd J. Kendall, MD

      Affiliations

    • Mobile Pathology Group, Mobile, AL 36602, USA
    • ,
  • Jon H. Ritter, MD

      Affiliations

    • Washington University Medical Center, St Louis, MO 63110, USA

References 

  1. King TE. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis, and management. Trans Am Clin Climatol Assoc. 2004;115:43–78
  2. Gefter WB, Conant EF. Issues and controversies in the plain-film diagnosis of asbestos-related disorders in the chest. J Thorac Imaging. 1988;3:11–28
  3. Ross RM. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest. 2003;124:1120–1128
  4. Gitlin JN, Cook LL, Linton OW, Garrett-Mayer E. Comparison of “B” readers' interpretations of chest radiographs for asbestos-related changes. Acad Radiol. 2004;11:843–856
  5. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;[in press]
  6. Ruangchira-Urai R, Colby TV, Klein J, Nielsen GP, Kradin FL, Mark EJ. Nodular amiodarone lung disease. Am J Surg Pathol. 2008;32:1654–1660
  7. Travis WD, Hunninghake G, King TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177:1338–1347
  8. Ryn HJ, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J. 2001;17:122–132
  9. Ryu JH, Colby TV, Hartman TE. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc. 1998;73:1085–1101
  10. Governa M, Amati M, Bellis D, Bichisecchi E, Santarelli L. Diagnosis of asbestos-related pleuropulmonary diseases. Med Lav. 2006;97:463–474
  11. Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis. 1991;144:477–478
  12. Miller A. Radiographic readings for asbestosis: misuse of science-validation of the ILO classification. Am J Indust Med. 2007;50:64–67
  13. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170:691–715
  14. Renn JJ. American Thoracic Society, American Bar Association, and asbestos. Am J Respir Crit Care Med. 2003;168:1399–1400
  15. Martin L. American Thoracic Society publishes biased, flawed review of non-malignant asbestos disease. http://www.lakesidepress.com/asbestos/AJRCCM-asbestos-statement.htm[Accessed 5-19-2009]
  16. Churg A. The diagnosis of asbestosis. Hum Pathol. 1989;20:97–99
  17. Holden J, Churg A. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers. Environ Res. 1986;39:232–236
  18. Churg A. Asbestos fiber content of the lungs in patients with and without asbestos airways disease. Am Rev Respir Dis. 1983;127:470–473
  19. Braun-Falco O. Senile actinic elastosis. Dermatol Int. 1965;4:232–237
  20. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982;106:544–596
  21. Carson FL. In: Histotechnology: a self-instructional text. 2nd ed.. Chicago: ASCP Press; 1997;p. 131–156
  22. Taylor CR, Shi SR, Barr NJ, Wu N. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In:  Dabbs DJ editors. Diagnostic immunohistochemistry. 2nd ed.. New York: Churchill-Livingstone; 2006;p. 1–42
  23. Dacic S, Yousem SA. Histologic classification of idiopathic chronic interstitial pneumonias. Am J Respir Cell Mol Biol. 2003;29(Suppl):S5–S9
  24. Fujimura N. Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med. 2000;6:140–144
  25. Silva CI, Muller NL, Neder JA, et al. Asbestos-related disease: progression of parenchymal abnormalities on high-resolution CT. J Thoracic Imaging. 2008;23:251–257
  26. Oksa P, Klockars M, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest. 1998;113:1517–1521
  27. Churg A. Non-neoplastic asbestos-induced disease. Mt. Sinai J Med. 1986;53:409–415
  28. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics. 2006;26:59–77
  29. Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology. 2003;229:731–736
  30. Akira M, Yamamoto S, Inoue Y, Sakatani M. High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. Am J Roentgenol. 2003;181:163–169
  31. Yamamoto S. Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. Osaka City Med J. 1997;43:225–242
  32. Churg A. Asbestos-related disease in the workplace and the environment: controversial issues. Monogr Pathol. 1993;36:54–77
  33. Miyachi Y, Ishikawa Q. Dermal connective tissue metabolism in photoaging. Australas J Dermatol. 1998;39:19–23
  34. Negri EM, Montes GS, Saldiva PH, Capelozzi VL. Architectural remodeling in acute and chronic interstitial lung disease: fibrosis or fibroelastosis. Histopathology. 2000;37:393–401
  35. Rozin GF, Gomes MM, Parra ER, et al. Collagen and elastic system in the remodeling process of major types of idiopathic interstitial pneumonias. Histopathology. 2005;46:413–421
  36. Parra ER, Kairalla RA, De Carvalho CR, Capelozzi VL. Abnormal deposition of collagen/elastic vascular fibers and prognostic significance in idiopathic interstitial pneumonias. Thorax. 2007;62:428–437
  37. Felicio CH, Parra ER, Capelozzi VL. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling processes. Lung. 2007;185:39–46
  38. Becker CD, Gil J, Padilla ML. Idiopathic pleuropulmonary fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008;21:784–787
  39. Nishimura Y, Nishike-Wada T, Wada Y, Miura Y, Otsuki T, Iguchi H. Long-lasting production of TGF-beta1 by alveolar macrophages exposed to low doses of asbestos without apoptosis. Int J Immunopathol Pharmacol. 2007;20:661–671
  40. Pociask DA, Sime PJ, Brody AR. Asbestos-derived reactive oxygen species activate TGF-beta1. Lab Invest. 2004;84:1013–1023
  41. Karonen T, Jeskanen L, Keski-Oja J. Transforming growth factor beta-1 and its latent form binding protein-1 associate with elastic fibers in human dermis: accumulation in actinic damage and absence in anetoderma. Br J Dermatol. 1997;137:51–58
  42. Hammar SP. Controversies and uncertainties concerning the pathologic features and pathologic diagnosis of asbestosis. Semin Diagn Pathol. 1992;9:102–109
  43. Gregor A, Parkes RW, du Bois R, Turner-Warwick M. Radiographic progression of asbestosis: preliminary report. Ann NY Acad Sci. 1979;330:147–156
  44. Suoranta H, Huuskonen MS, Zitting A, Juntunen J. Radiographic progression of asbestosis. Am J Ind Med. 1982;3:67–74
  45. Lilis R, Selikoff IJ, Lerman Y, Seidman H, Gelb SK. Asbestosis: interstitial pulmonary fibrosis and pleural fibrosis in a cohort of asbestos insulation workers: influence of cigarette smoking. Am J Ind Med. 1986;10:459–470
  46. Cookson W, De Klerk N, Musk AW, Glancy JJ, Armstrong B, Hobbs M. The natural history of asbestosis in former crocidolite workers of Wittenoom Gorge. Am Rev Respir Dis. 1986;133:994–998
  47. Grgic A, Lausberg H, Heinrich M, et al. Progression of fibrosis in usual interstitial pneumonia: serial evaluation of the native lung after single lung transplantation. Respiration. 2008;76:139–145
  48. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J. 2008;32:170–174
  49. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology, and regulation. Mucosal Immunol. 2009;2:103–121
  50. Boon K, Bailey NW, Yang J, et al. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS ONE. 2009;4:e5134

PII: S1092-9134(09)00057-4

doi: 10.1016/j.anndiagpath.2009.05.003

Annals of Diagnostic Pathology
Volume 13, Issue 5 , Pages 297-302 , October 2009

Article Tools

* Image Usage & Resolution